Evidence map›Paper›PMID 20409596›Full record

ArticleTrends in neurosciences2010

The sticky issue of neurosteroids and GABA(A) receptors.

Mariangela Chisari, Lawrence N Eisenman, Douglas F Covey, Steven Mennerick, Charles F Zorumski

Abstract read
In one paragraph

Article in Trends in neurosciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  2. Article
  3. The role of neuroactive steroids in tic disorders.Neuroscience and biobehavioral reviews · 2024
    Review
  4. Article
  5. Neurosteroid enantiomers as potentially novel neurotherapeutics.Neuroscience and biobehavioral reviews · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Neurosteroid regulation of GABABrain research · 2019
    Review
  14. Review
  15. Article
  16. Review
  17. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariangela ChisariDepartment of Psychiatry, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO 63110, USA.
Lawrence N Eisenman
Douglas F Covey
Steven Mennerick
Charles F Zorumski

Funding

STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUESP01GM047969 · NIGMS · WASHINGTON UNIVERSITY · PI COVEY, DOUGLAS F · 1992 to 2011
$18.7M
Washington University Center for Translational NeuroscienceP30NS057105 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2006 to 2011
$8.7M
CONTROL OF SYNAPTIC GLUTAMATE RELEASER01MH078823 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2006 to 2015
$3.2M
ETHANOL, NEUROSTEROIDS & HIPPOCAMPAL PLASTICITYR01AA017413 · NIAAA · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2009 to 2013
$1.8M
Axonal Signaling in the HippocampusR01NS054174 · NINDS · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2006 to 2010
$1.5M
NIAAA NIH HHS R01 AA017413NIGMS NIH HHS P01 GM047969NIMH NIH HHS R01 MH078823NINDS NIH HHS P30 NS057105NINDS NIH HHS R01 NS054174
6 · The paper itself

Abstract

Endogenous neurosteroids and their synthetic analogs (neuroactive steroids) are potent modulators of GABA(A) receptors. Thus, they are of physiological and clinical relevance for their ability to modulate inhibitory function in the CNS. Despite their importance, fundamental issues of neurosteroid actions remain unresolved. Recent evidence suggests that glutamatergic principal neurons, rather than glia, are the major sources of neurosteroid synthesis. Other recent studies have identified putative neurosteroid binding sites on GABA(A) receptors. In this Opinion, we argue that neurosteroids require a membranous route of access to transmembrane-domain binding sites within GABA(A) receptors. This has implications for the design of future neuroactive steroids because the lipid solubility and related accessibility properties of the ligand are likely to be key determinants of receptor modulation.

Indexed as

AnimalsBinding SitesCell MembraneCentral Nervous SystemModels, MolecularNeuronsNeurotransmitter AgentsProtein ConformationReceptors, GABA-ASynaptic TransmissionNeurotransmitter AgentsReceptors, GABA-A

Identifiers

PMID20409596
PMCPMC2902671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.